We assessed the relationship of renal function and the clinical outcome in 2314 patients treated by drug-eluting stent (DES). At 24 months, the cumulative major adverse cardiac events (MACE) rate and the composite of death and myocardial infarction were higher in the patients with severe chronic kidney disease (CKD). Severe CKD identifies patients at high risk of MACE following DES implantation.
Renal function and drug-eluting stent / Briguori, Carlo; Airoldi, Flavio; Chieffo, Alaide; Carlino, Mauro; Montorfano, M; Colombo, Antonio. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - (2010). [10.1016/j.ijcard.2008.11.138]
Renal function and drug-eluting stent
Chieffo Alaide;Montorfano M;
2010-01-01
Abstract
We assessed the relationship of renal function and the clinical outcome in 2314 patients treated by drug-eluting stent (DES). At 24 months, the cumulative major adverse cardiac events (MACE) rate and the composite of death and myocardial infarction were higher in the patients with severe chronic kidney disease (CKD). Severe CKD identifies patients at high risk of MACE following DES implantation.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
